Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Magda Zanelli is active.

Publication


Featured researches published by Magda Zanelli.


Pathology Research and Practice | 2015

Lymph node melanocytic nevi: Pathogenesis and differential diagnoses, with special reference to p16 reactivity

Simonetta Piana; Elena Tagliavini; Moira Ragazzi; Magda Zanelli; Iris Zalaudek; Alessia Ciarrocchi; Riccardo Valli

Lymph node nevi (NN) have been occasionally described, yet little is currently known on their origin. According to a theoretical model of nevogenesis, the dissemination of nevus progenitor cells through lymphatic routes is responsible for the development of both nodal and skin nevi. The true incidence of NN is largely unknown but it has been reported to vary from 0.017% to as high as 22%. The frequency of NN nevi has increased since the introduction of sentinel lymph node mapping as a routine prognostic procedure in breast cancer and melanoma. The aim of this study was to analyze the frequency and morphological findings of NN, to discuss possible pathogenetic pathways in their evolution, and to verify the consistency of p16 immunostaining in the critical differential approach between NN and melanoma metastases. We therefore morphologically and immunohistochemically evaluated a series of 60 NN from 58 patients. In 21 patients, the lymph nodes had been removed during the staging for a skin melanoma; in all these patients NN immunostaining with p16 was strongly positive and p16 proved to be a reliable marker for the crucial differential diagnosis between NN and melanoma metastasis, strongly reacting in NN and lacking in melanoma deposits. A deeper knowledge on NN could help to clarify some important topics such as lymph node metastatic melanoma with unknown primary and the current debate on the lymph node involvement from atypical spitzoid tumors.


Neuropathology | 2017

Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: Case description and review of the literature

Magda Zanelli; Moira Ragazzi; Giovanni Marchetti; Alessandra Bisagni; Massimo Principi; Daniela Fanni; Elisabetta Froio; Silvia Serra; Eleonora Zanetti; Loredana De Marco; Felice Giangaspero; Stefano Ascani

Histiocytic sarcoma is a rare malignant neoplasm arising most commonly in lymph nodes, intestinal tract, skin and soft tissue. The incidence of primary CNS histiocytic sarcoma is even rarer with a total of just 27 cases reported in the literature so far. Herein we describe the first autopsy case of histiocytic sarcoma presenting as a diffuse leptomeningeal disease in absence of a CNS tumor‐forming parenchymal lesion. The clinical, pathological and immunophenotypic features are described and an updated literature review on primary CNS histiocytic sarcoma is included.


Alimentary Pharmacology & Therapeutics | 2017

Letter: sprue‐like enteropathy associated with angiotensin II receptor blockers other than olmesartan

Magda Zanelli; Aurelio Negro; Rosaria Santi; Alessandra Bisagni; Moira Ragazzi; Stefano Ascani; L. De Marco

1. Kawaguchi-Suzuki M, Bril F, Kalavalapalli S, Cusi K, Frye RF. Concentration-dependent response to pioglitazone in nonalcoholic steato hepatitis. Aliment Pharmacol Ther. 2017;46:56-61. 2. Kalliokoski A, Neuvonen M, Neuvonen PJ, Niemi M. No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone. Br J Clin Pharmacol. 2008;65:78-86. 3. Chang KL, Pee HN, Yang S, Ho PC. Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer’s disease. Sci Rep. 2015;5:9000. 4. Itkonen MK, Tornio A, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT. Clopidogrel markedly increases plasma concentrations of CYP2C8 substrate pioglitazone. Drug Metab Dispos. 2016;44:1364-1371. 5. Kawaguchi-Suzuki M, Frye RF. Current clinical evidence on pioglitazone pharmacogenomics. Front Pharmacol. 2013;4:147.


Pathology Research and Practice | 2017

An Italian case of intestinal anisakiasis with a presurgical diagnosis: Could this parasite represent an emerging disease?

Magda Zanelli; Moira Ragazzi; Sirio Fiorino; Moira Foroni; Paolo Cecinato; Maria del Mar Jordana Sanchez; Stefano Ascani; Loredana De Marco

Anisakiasis is a parasitic infection caused by the consumption of raw fish containing larvae of the Anisakis species. Since the first description in 1960 of a patient suffering from this pathogen, in the Netherlands, most of the cases have been reported in Japan, where consumption of raw fish is common, but the number of cases is increasing worldwide. The first case identified in Italy dates back to 1996 and a few cases have been reported since then. In Italy the intestinal form occurs almost as frequently as the gastric form, which is far more frequent in Japan. Intestinal Anisakiasis represents a diagnostic challenge as it is clinically misdiagnosed and most of the patients require surgery due to the occurrence of complications such as bowel occlusion or perforation. Practically no cases of the intestinal form are diagnosed preoperatively. We report the first case, to our knowledge, of intestinal Anisakiasis in which surgery was avoided, due to a prompt diagnosis suspected on intestinal biopsies. A literature review of Anisakiasis cases reported in Italy is also carried out.


International Journal of Surgical Pathology | 2015

Anaplastic Lymphoma Kinase–Positive Large B-Cell Lymphoma Description of a Case With an Unexpected Clinical Outcome

Magda Zanelli; Riccardo Valli; Isabella Capodanno; Moira Ragazzi; Stefano Ascani

Anaplastic lymphoma kinase–positive (ALK-positive) large B-cell lymphoma is a rare and aggressive variant of large B-cell lymphoma (LBCL), first reported by Delsol et al in 1997, showing distinctive morphologic, immunophenotypic and cytogenetic features. The latest 2008 World Health Organization Classification of Tumours of Haematopoietic and Lymphoid tissues recognizes ALK-positive LBCL as a separate entity. Here, we report a case of ALK-positive large B-cell lymphoma in a 53-year-old man with diffuse abdominal and mediastinal lymph-nodes involvement. According to the Ann Arbor staging system, the patient had a stage IIIB lymphoma. The age-adjusted International Prognostic Index was 2 (stage III and elevated lactate dehydrogenase), so the disease was considered high risk. The patient underwent chemotherapy, radiotherapy, and an autologous stem cell transplantation. The patient is alive and free of disease 35 months after diagnosis.


Virchows Archiv | 2018

Primary classic Hodgkin lymphoma of the ileum and Epstein-Barr virus mucocutaneous ulcer of the colon: two entities compared

Magda Zanelli; Maria Cecilia Mengoli; Riccardo Valli; Elisabetta Froio; Alessandra Bisagni; Maurizio Zizzo; Loredana De Marco; Stefano Ascani

Primary classic Hodgkin lymphoma of the gastrointestinal tract represents a rare occurrence. A full patient’s work-up is essential in order to exclude a secondary intestinal involvement. Histologically Epstein-Barr virus mucocutaneous ulcer closely resembles Hodgkin lymphoma. The differential diagnosis between these two entities is relevant, since both the therapeutic approach and the clinical behavior are different. Herein, we describe a case of primary classic Hodgkin lymphoma arising in the ileum and a case of Epstein-Barr virus mucocutaneous ulcer of the colon, focusing on the main clinicopathological differences.


International Journal of Surgical Pathology | 2018

Diffuse Alveolar-Septal Amyloidosis Associated With Multiple Myeloma

Magda Zanelli; Maria Cecilia Mengoli; Francesco Puma; Lucia Spaggiari; Filippo Lococo; Loredana De Marco; Stefano Ascani

A 61-year-old woman presented with a recent history of progressive worsening dyspnea and dry cough without fever. Leucocyte, platelet counts, and hemoglobin level were within normal limits. Serum protein electrophoresis revealed the presence of IgG (kappa) monoclonal protein. Bone marrow biopsy findings were consistent with multiple myeloma with 15% plasma cells showing kappa light chain restriction. A thoracic computed tomography scan (Figure 1) disclosed septal thickening, ground glass attenuations, and minute centrolobular opacities, mainly located in the lower lobes. A wedge left lower lobe pulmonary resection was performed. Histology revealed interstitial and perivascular homogeneous densely eosinophilic material (Figure 2A) associated with plasma cellular infiltrate (Figure 2B) showing kappa light chain restriction (Figure 2C). The eosinophilic deposits were orange-red with Congo red stain and displayed apple-green birefringence under polarized light (Figure 2D). The final diagnosis was diffuse alveolar-septal amyloidosis in a patient with multiple myeloma. A bortezomib-based chemotherapy was started, followed by different chemotherapeutic regimens including cyclophosphamide, thalidomide, dexamethasone, and melphalan. The patient developed progressive respiratory distress and died 7 years after diagnosis. Amyloidosis comprises different diseases characterized by the deposition of congophilic amyloid fibrils in the extracellular matrix of different tissues and organs. Amyloidosis can be hereditary or acquired, localized or systemic. According to the World Health Organization classification, amyloidoses are defined by the different fibrillary proteins. In amyloidoses associated with an underlying plasma cell dyscrasia including multiple myeloma, the deposits are made up of immunoglobulin light chain (AL amyloidosis) or heavy chain (AH amyloidosis), with AL being the most common form. In AA amyloidosis there is tissue deposition of serum amyloid A, an α-globulin produced by the liver in different chronic inflammatory conditions. ATTR amyloidoses refer to the deposition of wild-type or mutated transthyretin in tissues, often the myocardium, in elderly patients. Three main histologic presentations of amyloidosis can occur in the lung: nodular pulmonary amyloidosis, tracheobronchial amyloidosis, and diffuse alveolar-septal amyloidosis, also known as diffuse parenchymal amyloidosis. Whereas nodular and tracheobronchial amyloidosis are 742200 IJSXXX10.1177/1066896917742200International Journal of Surgical PathologyZanelli et al research-article2017


Histopathology | 2018

Erdheim-Chester disease: Description of two illustrative cases involving the lung

Magda Zanelli; Maxwell L. Smith; Maria Cecilia Mengoli; Lucia Spaggiari; Loredana De Marco; Filippo Lococo; Francesco Puma; Stefano Ascani

Erdheim–Chester disease represents a clonal systemic proliferation of histiocytes. Bone is the most common site of involvement, although almost any organ, including the lungs, can be affected.


International Journal of Surgical Pathology | 2017

Multiple Myeloma With Multilobated Plasma Cells: An Unusual and Challenging Morphological Variant

Magda Zanelli; Maria Cecilia Mengoli; Daniela Fanni; Elisabetta Froio; Loredana De Marco; Stefano Ascani

A 70-year-old man presented with fatigue and severe back pain. He had a diagnosis of serum monoclonal gammopathy (IgG/kappa) that remained stable and asymptomatic for 7 years. On admission, the laboratory findings showed anemia with low hemoglobin level (9.5 g/dL), thrombocytopenia (31000/mmc), increased creatinine level (4 mg/ dL) with creatinine clearance 13 mL/min, hypercalcemia (14.3 mg/dL), and a serum B2 microglobulin of 1.4 mg/dL (normal value 0.10-0.25). Serum electrophoresis revealed a peak in the γ-globulin fraction, and immunofixation detected monoclonal IgG/kappa in serum (10.6 g/L) and kappa light chain in urine (3.28 mg/24 h). Bence Jones protein was present. Whole body radiographic scan and magnetic resonance imaging identified multiple lytic bone lesions in the cervical and thoracic spine and in the hip. Bone marrow biopsy showed a diffuse and massive infiltration by atypical, large multilobated and multinucleated cells with abundant cytoplasm (Figure 1), involving about 60% of bone marrow volume. The multilobated cells stained positive for CD138 (Figure 2A), MUM1/IRF4 (Figure 2B), and kappa chain (Figure 2C) and negative for CD20. A diagnosis of multiple myeloma with multilobated nuclei, stage III according Bartl, was made. Based on the cytogenetic abnormalities identified such as t(4;14), deletion of TP53/17p11, and gain (1q21), the myeloma was considered at high cytogenetic risk. After radiotherapy on bone lesions (total dose 25 Gy), the patient is currently on thalidomide, bortezomib, and dexametasone induction therapy for autologous stem cell transplantation. Multiple myeloma with multilobated/multinucleated plasma cells is a very uncommon (2% to 8%) morphological variant often characterized by an aggressive clinical course. The unusual morphological features of large bizarre multilobated plasma cells can make its diagnosis difficult to achieve. Immunohistochemistry is essential in order to avoid misdiagnosis especially with myeloid/ monocytic leukemia or nonhematological malignancies.


British Journal of Clinical Pharmacology | 2017

Chemical gastritis and colitis related to hydrogen peroxide mouthwash.

Magda Zanelli; Moira Ragazzi; Loredana De Marco

Hydrogen peroxide is a commonly used oxidizing agent with different uses depending on its concentration. Three percent solutions are used as common household disinfectants for superficial wounds. Hydrogen peroxide has been utilized widely throughout medical history. Clinical applications involving the gastrointestinal tract have included rectal enema to relieve faecal impactions in adults or meconium ileus in newborns. Nowadays most of these practices have been abandoned due to severe intestinal iatrogenic injuries [3]. Ingestion of 3% hydrogen peroxide is usually considered to be relatively nontoxic, producing only minimal gastrointestinal irritation [4]. We report a case of chemical gastritis and colitis after use of mouthwash with 3% hydrogen peroxide solution. Patient consent was obtained. A 54-year-old woman presented to our institution complaining of acute epigastric and abdominal pain associated with postprandial, nonbloody diarrhoea. She also suffered from mild pharyngalgia and a sore mouth. The symptoms had lasted for about 2 months becoming progressively worse. The patient was afebrile. Her past medical history was unremarkable. She denied taking any medication. Physical examination revealed a mild diffuse abdominal tenderness. Her blood examinations were within normal limits. Upper and lower gastrointestinal endoscopy did not reveal any abnormalities. Multiple gastric biopsies showed mild gastritis with focal superficial erosions. Microscopic examination of multiple colorectal biopsies revealed mucosal oedema, vascular congestion and mild gland atrophy. An increase in apoptotic bodies in the cryptal epithelium of the colorectal mucosa was also noted. The pathological features appeared consistent with mild ischemic colorectal damage. However, the presence of apoptosis in the crypt epithelium raised the possibility of a drug effect [5]. A detailed clinical history disclosed that the patient was having an endodontic root canal procedure to treat an infected tooth when the gastrointestinal symptoms had started. The endodontic treatment was performed once a week for 2 months. During each session 50 ml of a 3% hydrogen peroxide solution was applied to clean out and disinfect the root canal. Isolation devices to prevent the patient from swallowing the product, such as dental dams, were not used and presumably a large amount of the hydrogen peroxide solution was ingested. The gastrointestinal symptoms had started approximately 4 weeks after the beginning of the endodontic procedure and had become progressively worse during the 2-month treatment period. After suspension of the mouthwash the patient achieved a complete resolution of gastrointestinal symptoms. The history of hydrogen peroxide toxicity in the gastrointestinal tract dates back to its use with enema causing severe colonic damage similar to that of ulcerative colitis or pseudomembranous colitis [6]. Cases of chemical colitis have also been reported to occur as a result of accidental British Journal of Clinical Pharmacology Br J Clin Pharmacol (2017) 83 427–428 427

Collaboration


Dive into the Magda Zanelli's collaboration.

Top Co-Authors

Avatar

Loredana De Marco

Santa Maria Nuova Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maria Cecilia Mengoli

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Moira Ragazzi

Santa Maria Nuova Hospital

View shared research outputs
Top Co-Authors

Avatar

Riccardo Valli

Santa Maria Nuova Hospital

View shared research outputs
Top Co-Authors

Avatar

Maurizio Zizzo

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Filippo Lococo

The Catholic University of America

View shared research outputs
Top Co-Authors

Avatar

Alberto Cavazza

Santa Maria Nuova Hospital

View shared research outputs
Top Co-Authors

Avatar

Aurelio Negro

Santa Maria Nuova Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge